AEs	Adverse events
AJCC	American Joint Committee on Cancer
CRT	Chemoradiotherapy
CT	Computed tomography
CTLA-4	Cytotoxic T-lymphocyte-associated antigen 4
EGFR	Epidermal growth factor receptor
ESMO	European Society of Medical Oncology
ICI	Immune checkpoint inhibitors
IV	Intravenous
MPR	Major pathological response
NCCN	National Comprehensive Cancer Network
NSCLC	Non small-cell lung cancer
OS	Overall survival
pCR	Pathological complete response
PD-1	Programmed death 1
PD-L1	Programmed death-ligand 1
PET/CT	Positron emission tomography/computed tomography
PFS	Progression-free survival
RT	Radiation therapy
SUV	Standardized uptake values
TKI	Tyrosine kinase inhibitors
TMB	Tumor mutational burden
TNM	Tumor, Node, and Metastasis staging system of American Joint Committee on Cancer